Listed

Arbutus Biopharma Corp

ABUSNasdaqCIK 1447028HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$1.0m, Q2 FY2026
Operating income−$6.0m, Q2 FY2026
Net income−$5.1m, Q2 FY2026
Arbutus Biopharma Corp, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m4.7Revenue, Q3 FY2023, three months to 2023-09-30$4.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figure2.1Revenue, Q4 FY2023, three months to 2023-12-31$2.1m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-27, accession 0001447028-25-000083. Derived: 12-month figure less the 9-month figure.Report this figure1.5Revenue, Q1 FY2024, three months to 2024-03-31$1.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure1.7Revenue, Q2 FY2024, three months to 2024-06-30$1.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-06, accession 0001447028-25-000115.Report this figure1.3Revenue, Q3 FY2024, three months to 2024-09-30$1.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure1.6Revenue, Q4 FY2024, three months to 2024-12-31$1.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure1.8Revenue, Q1 FY2025, three months to 2025-03-31$1.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure10.7Revenue, Q2 FY2025, three months to 2025-06-30$10.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure0.5Revenue, Q3 FY2025, three months to 2025-09-30$529.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure1.1Revenue, Q4 FY2025, three months to 2025-12-31$1.1m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure179Revenue, Q1 FY2026, three months to 2026-03-31$179.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure1.0Revenue, Q2 FY2026, three months to 2026-06-30$1.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure
Research and development$m20.2Research and development, Q3 FY2023, three months to 2023-09-30$20.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figure17.6Research and development, Q4 FY2023, three months to 2023-12-31$17.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-27, accession 0001447028-25-000083. Derived: 12-month figure less the 9-month figure.Report this figure15.4Research and development, Q1 FY2024, three months to 2024-03-31$15.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure15.6Research and development, Q2 FY2024, three months to 2024-06-30$15.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001447028-25-000115.Report this figure14.3Research and development, Q3 FY2024, three months to 2024-09-30$14.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure8.8Research and development, Q4 FY2024, three months to 2024-12-31$8.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure9.0Research and development, Q1 FY2025, three months to 2025-03-31$9.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure5.5Research and development, Q2 FY2025, three months to 2025-06-30$5.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure5.8Research and development, Q3 FY2025, three months to 2025-09-30$5.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure5.0Research and development, Q4 FY2025, three months to 2025-12-31$5.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure4.1Research and development, Q1 FY2026, three months to 2026-03-31$4.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure2.9Research and development, Q2 FY2026, three months to 2026-06-30$2.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure
Operating income$m(21.6)Operating income, Q3 FY2023, three months to 2023-09-30−$21.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figure(20.7)Operating income, Q4 FY2023, three months to 2023-12-31−$20.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-27, accession 0001447028-25-000083. Derived: 12-month figure less the 9-month figure.Report this figure(19.4)Operating income, Q1 FY2024, three months to 2024-03-31−$19.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure(21.6)Operating income, Q2 FY2024, three months to 2024-06-30−$21.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001447028-25-000115.Report this figure(21.4)Operating income, Q3 FY2024, three months to 2024-09-30−$21.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure(13.9)Operating income, Q4 FY2024, three months to 2024-12-31−$13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(25.7)Operating income, Q1 FY2025, three months to 2025-03-31−$25.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure1.5Operating income, Q2 FY2025, three months to 2025-06-30$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure(8.7)Operating income, Q3 FY2025, three months to 2025-09-30−$8.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure(5.3)Operating income, Q4 FY2025, three months to 2025-12-31−$5.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure169Operating income, Q1 FY2026, three months to 2026-03-31$168.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure(6.0)Operating income, Q2 FY2026, three months to 2026-06-30−$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$46.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-07, accession 0001447028-23-000090.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$44.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-05, accession 0001447028-24-000035. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$44.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-02, accession 0001447028-24-000038.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$34.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-08, accession 0001447028-24-000072.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$29.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$30.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$28.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$28.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$23.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$18.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$17.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$18.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2023-11-07, accession 0001447028-23-000090.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-27, accession 0001447028-25-000083. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-12, accession 0001447028-26-000045. Derived: 6-month figure less the 3-month figure.Report this figure
Net income$m(20.1)Net income, Q3 FY2023, three months to 2023-09-30−$20.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figure(19.3)Net income, Q4 FY2023, three months to 2023-12-31−$19.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-27, accession 0001447028-25-000083. Derived: 12-month figure less the 9-month figure.Report this figure(17.9)Net income, Q1 FY2024, three months to 2024-03-31−$17.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure(19.8)Net income, Q2 FY2024, three months to 2024-06-30−$19.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure(19.7)Net income, Q3 FY2024, three months to 2024-09-30−$19.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure(12.5)Net income, Q4 FY2024, three months to 2024-12-31−$12.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(24.5)Net income, Q1 FY2025, three months to 2025-03-31−$24.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure2.5Net income, Q2 FY2025, three months to 2025-06-30$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure(7.7)Net income, Q3 FY2025, three months to 2025-09-30−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure(3.8)Net income, Q4 FY2025, three months to 2025-12-31−$3.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure170Net income, Q1 FY2026, three months to 2026-03-31$169.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure(5.1)Net income, Q2 FY2026, three months to 2026-06-30−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure
Diluted EPS$ per share(0.12)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figurenot reported(0.10)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure(0.11)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001447028-25-000115.Report this figure(0.10)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figurenot reported(0.13)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure0.01Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure(0.04)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figurenot reported0.87Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.87 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure(0.03)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure
Basic EPS$ per share(0.12)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figurenot reported(0.10)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure(0.11)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001447028-25-000115.Report this figure(0.10)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figurenot reported(0.13)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure0.01Basic EPS, Q2 FY2025, three months to 2025-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure(0.04)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figurenot reported0.88Basic EPS, Q1 FY2026, three months to 2026-03-31$0.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure(0.03)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure

Balance sheet

Cash and equivalents$19.2m, Q2 FY2026
Long-term debt$0, Q2 FY2026
Shareholders' equity$258.7m, Q2 FY2026
Arbutus Biopharma Corp, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m17.5Cash and equivalents, Q3 FY2023, at 2023-09-30$17.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-07, accession 0001447028-23-000090.Report this figure26.3Cash and equivalents, FY2023, at 2023-12-31$26.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-27, accession 0001447028-25-000083.Report this figure43.1Cash and equivalents, Q1 FY2024, at 2024-03-31$43.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-02, accession 0001447028-24-000038.Report this figure62.8Cash and equivalents, Q2 FY2024, at 2024-06-30$62.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001447028-24-000072.Report this figure31.8Cash and equivalents, Q3 FY2024, at 2024-09-30$31.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figure36.3Cash and equivalents, FY2024, at 2024-12-31$36.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-23, accession 0001447028-26-000017.Report this figure37.1Cash and equivalents, Q1 FY2025, at 2025-03-31$37.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure37.4Cash and equivalents, Q2 FY2025, at 2025-06-30$37.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001447028-25-000115.Report this figure22.4Cash and equivalents, Q3 FY2025, at 2025-09-30$22.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure18.0Cash and equivalents, FY2025, at 2025-12-31$18.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure23.7Cash and equivalents, Q1 FY2026, at 2026-03-31$23.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure19.2Cash and equivalents, Q2 FY2026, at 2026-06-30$19.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure
Current assets$m142Current assets, Q3 FY2023, at 2023-09-30$141.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0001447028-23-000090.Report this figure132Current assets, FY2023, at 2023-12-31$132.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-27, accession 0001447028-25-000083.Report this figure136Current assets, Q1 FY2024, at 2024-03-31$135.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0001447028-24-000038.Report this figure148Current assets, Q2 FY2024, at 2024-06-30$148.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001447028-24-000072.Report this figure133Current assets, Q3 FY2024, at 2024-09-30$132.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figure127Current assets, FY2024, at 2024-12-31$127.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-23, accession 0001447028-26-000017.Report this figure117Current assets, Q1 FY2025, at 2025-03-31$116.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure103Current assets, Q2 FY2025, at 2025-06-30$103.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001447028-25-000115.Report this figure97.4Current assets, Q3 FY2025, at 2025-09-30$97.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure94.5Current assets, FY2025, at 2025-12-31$94.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure277Current assets, Q1 FY2026, at 2026-03-31$277.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure274Current assets, Q2 FY2026, at 2026-06-30$273.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure
Total assets$m159Total assets, Q3 FY2023, at 2023-09-30$158.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001447028-23-000090.Report this figure144Total assets, FY2023, at 2023-12-31$144.4m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-27, accession 0001447028-25-000083.Report this figure150Total assets, Q1 FY2024, at 2024-03-31$150.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0001447028-24-000038.Report this figure160Total assets, Q2 FY2024, at 2024-06-30$160.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001447028-24-000072.Report this figure140Total assets, Q3 FY2024, at 2024-09-30$140.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figure132Total assets, FY2024, at 2024-12-31$131.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-23, accession 0001447028-26-000017.Report this figure117Total assets, Q1 FY2025, at 2025-03-31$117.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure103Total assets, Q2 FY2025, at 2025-06-30$103.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001447028-25-000115.Report this figure97.7Total assets, Q3 FY2025, at 2025-09-30$97.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure94.6Total assets, FY2025, at 2025-12-31$94.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure277Total assets, Q1 FY2026, at 2026-03-31$277.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure274Total assets, Q2 FY2026, at 2026-06-30$274.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure
Current liabilities$m22.3Current liabilities, Q3 FY2023, at 2023-09-30$22.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0001447028-23-000090.Report this figure22.5Current liabilities, FY2023, at 2023-12-31$22.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-27, accession 0001447028-25-000083.Report this figure20.3Current liabilities, Q1 FY2024, at 2024-03-31$20.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0001447028-24-000038.Report this figure22.6Current liabilities, Q2 FY2024, at 2024-06-30$22.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001447028-24-000072.Report this figure18.9Current liabilities, Q3 FY2024, at 2024-09-30$18.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figure15.6Current liabilities, FY2024, at 2024-12-31$15.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-23, accession 0001447028-26-000017.Report this figure19.4Current liabilities, Q1 FY2025, at 2025-03-31$19.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure5.0Current liabilities, Q2 FY2025, at 2025-06-30$5.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001447028-25-000115.Report this figure5.2Current liabilities, Q3 FY2025, at 2025-09-30$5.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure6.0Current liabilities, FY2025, at 2025-12-31$6.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure5.1Current liabilities, Q1 FY2026, at 2026-03-31$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure3.4Current liabilities, Q2 FY2026, at 2026-06-30$3.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure
Total liabilities$m39.3Total liabilities, Q3 FY2023, at 2023-09-30$39.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0001447028-23-000090.Report this figure38.4Total liabilities, FY2023, at 2023-12-31$38.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-27, accession 0001447028-25-000083.Report this figure35.7Total liabilities, Q1 FY2024, at 2024-03-31$35.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-02, accession 0001447028-24-000038.Report this figure37.6Total liabilities, Q2 FY2024, at 2024-06-30$37.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001447028-24-000072.Report this figure33.6Total liabilities, Q3 FY2024, at 2024-09-30$33.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figure34.3Total liabilities, FY2024, at 2024-12-31$34.3m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-23, accession 0001447028-26-000017.Report this figure37.9Total liabilities, Q1 FY2025, at 2025-03-31$37.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure20.3Total liabilities, Q2 FY2025, at 2025-06-30$20.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001447028-25-000115.Report this figure20.3Total liabilities, Q3 FY2025, at 2025-09-30$20.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure18.0Total liabilities, FY2025, at 2025-12-31$18.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure17.0Total liabilities, Q1 FY2026, at 2026-03-31$17.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure15.3Total liabilities, Q2 FY2026, at 2026-06-30$15.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure
Long-term debt$m0.0Long-term debt, Q3 FY2023, at 2023-09-30$0. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-07, accession 0001447028-23-000090.Report this figure0.0Long-term debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebt. 10-K filed 2024-03-05, accession 0001447028-24-000035.Report this figure0.0Long-term debt, Q1 FY2024, at 2024-03-31$0. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-02, accession 0001447028-24-000038.Report this figure0.0Long-term debt, Q2 FY2024, at 2024-06-30$0. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-08, accession 0001447028-24-000072.Report this figure0.0Long-term debt, Q3 FY2024, at 2024-09-30$0. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figure0.0Long-term debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-27, accession 0001447028-25-000083.Report this figure0.0Long-term debt, Q1 FY2025, at 2025-03-31$0. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure0.0Long-term debt, Q2 FY2025, at 2025-06-30$0. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-06, accession 0001447028-25-000115.Report this figure0.0Long-term debt, Q3 FY2025, at 2025-09-30$0. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure0.0Long-term debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-23, accession 0001447028-26-000017.Report this figure0.0Long-term debt, Q1 FY2026, at 2026-03-31$0. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure0.0Long-term debt, Q2 FY2026, at 2026-06-30$0. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure
Shareholders' equity$m119Shareholders' equity, Q3 FY2023, at 2023-09-30$119.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figure106Shareholders' equity, FY2023, at 2023-12-31$106.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-23, accession 0001447028-26-000017.Report this figure115Shareholders' equity, Q1 FY2024, at 2024-03-31$114.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure122Shareholders' equity, Q2 FY2024, at 2024-06-30$122.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure107Shareholders' equity, Q3 FY2024, at 2024-09-30$106.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure97.4Shareholders' equity, FY2024, at 2024-12-31$97.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure79.2Shareholders' equity, Q1 FY2025, at 2025-03-31$79.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure83.0Shareholders' equity, Q2 FY2025, at 2025-06-30$83.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure77.4Shareholders' equity, Q3 FY2025, at 2025-09-30$77.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure76.6Shareholders' equity, FY2025, at 2025-12-31$76.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure260Shareholders' equity, Q1 FY2026, at 2026-03-31$260.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure259Shareholders' equity, Q2 FY2026, at 2026-06-30$258.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure

Cash flow

Operating cash flow−$6.0m, Q2 FY2026
Capital expenditure$0, Q4 FY2025
Arbutus Biopharma Corp, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(21.8)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$21.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-06, accession 0001447028-24-000087. Derived: 9-month figure less the 6-month figure.Report this figure(17.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$17.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-27, accession 0001447028-25-000083. Derived: 12-month figure less the 9-month figure.Report this figure(19.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$19.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure(14.5)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$14.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001447028-25-000115. Derived: 6-month figure less the 3-month figure.Report this figure(20.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$20.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001447028-25-000126. Derived: 9-month figure less the 6-month figure.Report this figure(10.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$10.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(13.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$13.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure(15.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$15.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001447028-26-000045. Derived: 6-month figure less the 3-month figure.Report this figure(5.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001447028-25-000126. Derived: 9-month figure less the 6-month figure.Report this figure(4.7)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure(8.1)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$8.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure(6.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$6.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001447028-26-000045. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$32.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-06, accession 0001447028-24-000087. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-27, accession 0001447028-25-000083. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$95.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001447028-25-000115. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001447028-25-000126. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$86.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001447028-25-000115. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001447028-25-000126. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-23, accession 0001447028-26-000017. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)197.47m, Q2 FY2026
Arbutus Biopharma Corp, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares151Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30150,995,191 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0001447028-23-000090.Report this figure162Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31161,643,404 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-02, accession 0001447028-24-000038.Report this figure166Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30166,063,284 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001447028-24-000072.Report this figure168Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30167,512,708 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-06, accession 0001447028-24-000087.Report this figure176Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31175,625,552 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001447028-25-000099.Report this figure188Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30188,041,489 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001447028-25-000115.Report this figure189Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30188,997,194 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure191Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31190,707,085 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure192Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30192,399,733 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure192Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30191,778,950 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001447028-25-000126.Report this figure195Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31195,214,067 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001447028-26-000021.Report this figure197Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30197,470,724 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure

Shares outstanding: 197.85mShares outstanding, period not labelled, at 2026-08-10197,847,835 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001447028-26-000045.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.